Guiding Novel Neurologic Drug Approvals

The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.

Understanding Cholesterol Therapy: An Update for Community Pharmacists

Elevated total and LDL cholesterol predispose patients to an increased risk of cardiovascular disease and mortality.

Benefits and Complications of Sodium-Glucose Cotransporter 2 Inhibitors

This drug class confers benefits in diabetic patients with heart failure, CV disease, and renal disease, but it is also associated with major adverse events.

Applying HIV/AIDS Lessons to the Opioid Crisis

Successful programs feature a mix of social and scientific components.

Tylenol Cold & Flu Q&A

Quick Poll

How well is the Poll admin working for you?